[HTML][HTML] New insights into the evasion of host innate immunity by Mycobacterium tuberculosis

Q Chai, L Wang, CH Liu, B Ge - Cellular & molecular immunology, 2020 - nature.com
Mycobacterium tuberculosis (Mtb) is an extremely successful intracellular pathogen that
causes tuberculosis (TB), which remains the leading infectious cause of human death. The …

[HTML][HTML] Host-directed therapies for bacterial and viral infections

SHE Kaufmann, A Dorhoi, RS Hotchkiss… - Nature reviews Drug …, 2018 - nature.com
Despite the recent increase in the development of antivirals and antibiotics, antimicrobial
resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and …

[HTML][HTML] The immunoregulatory landscape of human tuberculosis granulomas

EF McCaffrey, M Donato, L Keren, Z Chen… - Nature …, 2022 - nature.com
Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in
infected tissues, the architecture and composition of which are thought to affect disease …

Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport

FJ Roca, LJ Whitworth, HA Prag, MP Murphy… - Science, 2022 - science.org
Tumor necrosis factor (TNF) is a critical host resistance factor against tuberculosis. However,
excess TNF produces susceptibility by increasing mitochondrial reactive oxygen species …

Immunology of Mycobacterium tuberculosis Infections

JK Sia, J Rengarajan - Microbiology spectrum, 2019 - Am Soc Microbiol
Tuberculosis (TB) is a serious global public health challenge that results in significant
morbidity and mortality worldwide. TB is caused by infection with the bacilli Mycobacterium …

[HTML][HTML] Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment

A Allué-Guardia, JI García, JB Torrelles - Frontiers in Microbiology, 2021 - frontiersin.org
In the last two decades, multi (MDR), extensively (XDR), extremely (XXDR) and total (TDR)
drug-resistant Mycobacterium tuberculosis (M. tb) strains have emerged as a threat to public …

Heterogeneity in tuberculosis

AM Cadena, SM Fortune, JAL Flynn - Nature Reviews Immunology, 2017 - nature.com
Infection with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), results
in a range of clinical presentations in humans. Most infections manifest as a clinically …

Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny

L Huang, EV Nazarova, S Tan, Y Liu… - Journal of Experimental …, 2018 - rupress.org
To understand how infection by Mycobacterium tuberculosis (Mtb) is modulated by host cell
phenotype, we characterized those host phagocytes that controlled or supported bacterial …

[HTML][HTML] Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

L Moreira-Teixeira, PJ Stimpson, E Stavropoulos… - Nature …, 2020 - nature.com
Tuberculosis (TB) is a leading cause of mortality due to infectious disease, but the factors
determining disease progression are unclear. Transcriptional signatures associated with …

[HTML][HTML] Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management

D Liebenberg, BG Gordhan, BD Kana - Frontiers in cellular and …, 2022 - frontiersin.org
Drug resistant tuberculosis contributes significantly to the global burden of antimicrobial
resistance, often consuming a large proportion of the healthcare budget and associated …